reviewExperimental Biology and MedicineJan 1, 2003Closed access

Erythropoietin: Physiology and Pharmacology Update

Tulane University

PubMed
Indexed incrossrefdoajpubmed

Abstract

This minireview is an update of a 1997 review on erythropoietin (EPO) in this journal. EPO is a 30,400-dalton glycoprotein that regulates red cell production. In the human, EPO is produced by peritubular cells in the kidneys of the adult and in hepatocytes in the fetus. Small amounts of extra-renal EPO are produced by the liver in adult human subjects. EPO binds to an erythroid progenitor cell surface receptor that includes a p66 chain, and, when activated, the p66 protein becomes dimerized. EPO receptor activation induces a JAK2 tyrosine kinase, which leads to tyrosine phosphorylation of the EPO receptor and several proteins. EPO receptor binding leads to intracellular activation of the Ras/mitogen-activated…

Citation impact

705
total citations
FWCI
16.80
Percentile
100%
References
190
Citations per year

Authors

1

Topics & keywords

Keywords
  • Erythropoietin
  • Erythropoietin receptor
  • Biology
  • Cell biology
  • CREB
  • Receptor tyrosine kinase
  • Signal transduction
  • Kinase
No related works found for this paper.